A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy

MLA

Andreas Hillenbrand, et al. “A Longterm Follow-up Study of Thymidylate Synthase as a Predictor for Survival of Patients with Liver Tumours Receiving Hepatic Arterial Infusion Chemotherapy.” European Journal of Surgical Oncology (EJSO), vol. 30, May 2004, pp. 407–13. EBSCOhost, https://doi.org/10.1016/j.ejso.2004.01.012.

APA

Andreas Hillenbrand, Marko Kornmann, Silvia Sander, Ludger Staib, Peter V. Danenberg, Andrea Formentini, K. Danenberg, & Dennis Salonga. (2004). A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy. European Journal of Surgical Oncology (EJSO), 30, 407–413. https://doi.org/10.1016/j.ejso.2004.01.012

Chicago

Andreas Hillenbrand, Marko Kornmann, Silvia Sander, Ludger Staib, Peter V. Danenberg, Andrea Formentini, K. Danenberg, and Dennis Salonga. 2004. “A Longterm Follow-up Study of Thymidylate Synthase as a Predictor for Survival of Patients with Liver Tumours Receiving Hepatic Arterial Infusion Chemotherapy.” European Journal of Surgical Oncology (EJSO) 30 (May): 407–13. doi:10.1016/j.ejso.2004.01.012.